321550 — TiumBio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩185bn
Enterprise Value
KR₩188bn
Revenue
KR₩7bn

Annual balance sheet for TiumBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	68,576	40,635	18,130	34,409	47,655
Net Total Accounts Receivable
Net Total Receivables	957	1,102	19,535	8,550	5,342
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	69,851	41,901	40,295	45,311	58,914
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,682	14,826	24,362	42,031	44,721
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	85,351	116,735	96,259	119,546	107,298
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,777	4,467	30,110	11,666	39,340
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,845	29,162	35,221	49,468	54,826
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	82,507	87,573	61,038	70,078	52,473
Total Liabilities & Shareholders' Equity	85,351	116,735	96,259	119,546	107,298
Total Common Shares Outstanding
Total Preferred Shares Outstanding